Vulnerable atherosclerotic plaques with unique biological signatures are responsible for most major cardiovascular events including acute myocardial infarction and stroke. However, current clinical diagnostic approaches for atherosclerosis focus on anatomical measurements such as the degree of luminal stenosis and wall thickness. An abundance of neovessels with elevated expression of integrin α v β 3 is closely associated with an increased risk of plaque rupture. Herein we evaluated the potential of an α v β 3 integrin-targeting radiotracer, Cardiovascular diseases are the number one cause of morbidity and mortality worldwide 1 . By 2030, they are projected to be the single leading cause of death globally 2 . Rupture of atherosclerotic plaques (i.e., atheromatous plaques in the inner lining of the arteries) is a critical feature leading to major clinical events such as acute myocardial infarction, sudden cardiac death, and stroke. Monitoring plaque progression and identifying vulnerability may help prevent these events and reduce the burden of cardiovascular disease 3 . At present, clinicians lack reliable tools to detect high-risk plaques that are rupture-prone and
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Scientific RepoRts | 5:11752 | DOi: 10.1038/srep11752 to predict the location of possible adverse events 3, 4 . Current diagnostic strategies predominantly focus on anatomical issues such as myocardial ischemia 5 , hemodynamic luminal narrowing, or morphological abnormalities of atheromas, but not on the biological aspects of atherosclerotic lesions. This traditional strategy has proven disappointing in preventing myocardial infarction or prolonging life, except in limited patient groups [6] [7] [8] . Atherosclerotic plaques comprise a heterogeneous mixture of cellular and acellular elements 9 . In the past decade, considerable efforts have been devoted to determine the specific compositional features of unstable vulnerable plaques [9] [10] [11] [12] . Atherosclerotic plaques at the highest risk of rupture clearly exhibit a large lipid-rich necrotic core, thin fibrous cap, neovascularization, spotty calcium, and abundant inflammatory cells; these features are distinctive from those of stable lesions [9] [10] [11] . Therefore, the assessment of plaque composition is potentially more important than the traditional detection of simple intraluminal stenosis for predicting devastating arterial events 7, 8, 13, 14 . As a result, there is a compelling need to develop diagnostic imaging techniques to gauge the biological details of plaques that trigger the conversion of asymptomatic atheromas to rupture-prone lesions and subsequent fatal thrombosis. Molecular imaging strategies now provide an approach other than assessing vessel stenosis and wall thickness, and shed light on the in vivo pathology of atherosclerotic plaques [13] [14] [15] [16] . In particular, neovascularization is a key process of advanced atherosclerotic plaques and an independent predictor of future adverse clinical outcomes [17] [18] [19] . Newly formed vasculature within a plaque is closely related to the inflammatory process, which is another important determinant of plaque rupture because it facilitates monocyte recruitment and transmigration. Intraplaque hemorrhage, a critical event that provokes lesion destabilization by providing erythrocyte-derived phospholipids and free cholesterol, is caused by damage to neovessels because of their immature, fragile characteristics resulting from the lack of smooth muscle cells 20 . Aspects of neoangiogenesis have therefore surfaced as emerging major targets for molecular imaging of atherosclerosis. Angiogenesis has been extensively studied for cancer diagnosis 21 ; however, imaging neovasculature to identify patients at risk for major clinical manifestations of atherosclerosis is relatively new, compared to the long history of imaging plaque inflammation [22] [23] [24] . Previous investigations of imaging neovascular proliferation in plaques are limited to trials using nanoparticle-enhanced molecular magnetic resonance imaging (MRI) 25, 26 and to a few recent studies using positron emission tomography (PET) with simple arginyl-glycyl-aspartic acid (RGD) monomer peptides 27, 28 . The RGD, an excellent targeting moiety for integrin α v β 3 of activated endothelial cells, has been successfully validated for imaging tumor angiogenesis in numerous preclinical and clinical studies 21, 29, 30 . We recently developed a new radiotracer, Compared to other reported RGD monomer-based agents 30, 32, 33 [e.g., Tc-(CO) 3 -pyrazoyl conjugate of c(RGDyK) 34 and Tc-IDA-D-[c(RGDfK)] 2 showed specific integrin-binding affinity, high tumor accumulation and desirable pharmacokinetic properties for tumor xenograft imaging 31 . Similar to tumor angiogenesis imaging, this radiotracer is expected to be effective for imaging neovessel-rich atherosclerotic plaques and show better imaging performance compared with previously reported monomeric RGD probe based approaches 27, 28 . Here we describe a molecular imaging strategy that uses α v β 3 integrin-targeted probe 99m Tc-IDA-D-[c(RGDfK)] 2 with SPECT to achieve improved atherosclerosis staging through assessment of neovascularization. To illustrate the utility of this approach, we demonstrate SPECT/CT imaging of atherosclerotic mouse models and analyze correlation between in vivo uptake of the radiotracer and ex vivo autoradiography signal and corresponding histopathological signatures. Comparative measurements with conventional monomeric RGD derivatives reveal superior sensitivity of the designed dimer RGD probe for noninvasive nuclear imaging as well as tissue fluorescence imaging. Finally we discuss the potential of angiogenesis targeted approach for ideal noninvasive imaging to pinpoint high-risk atherosclerotic plaques before they lead to fatal clinical events.
Results

Development of High-risk Atherosclerosis and Validation Studies.
To explore the ability of α v β 3 integrin-targeted probes to detect atherosclerotic lesions with a high risk of rupture, we established mouse models of atherosclerosis by feeding a high-cholesterol diet to apoE-deficient (ApoE-/-) mice. After 40 weeks of this special diet, their hearts and aortas were excised and carefully analyzed. As Fig. 1A shows, atherosclerotic lesions (white areas) were present in the aorta-predominantly in the aortic arch; in the origins of the brachiocephalic, left subclavian, and left common carotid arteries; and throughout the thoracic and abdominal aorta. After the gross anatomical examination, we performed Oil-Red-O (ORO) staining of the excised aortic arch tissues and descending aortas in the apoE transgenic mice and the wild-type C57BL/6J mice (Figs 1B,C). Lipid pool zones with a strong ORO-positive response were identified in the apoE-deficient mice, compared to the control mice, which demonstrated significant development of lipid-rich high-risk lesions; this was observed in a previous study 35 . The x-ray CT scans with a vascular contrast agent revealed detailed anatomy of heart and aorta regions, which included the aortic arch and descending aorta structures (Figs 1D-I). As a complement to SPECT imaging, x-ray CT provides structural high-resolution visualization of specific locations for developed atherosclerotic lesions. Tc-IDA-D-[c(RGDfK)] 2 , a diagnostic imaging agent for angiogenesis with chemical and radiochemical purities greater than 99% and specific activity greater than 55 GBq/μ mol. This agent was designed to have enhanced hydrophilicity of the integrin-binding RGD dimer peptide. Its superior pharmacokinetic properties and high metabolic stability have been proven in a previous study 31 . Herein we evaluated the feasibility of SPECT/CT imaging using Tc-pertechnetate in a transgenic mouse showed no specific accumulation in the same territories and only nonspecific uptake in the salivary glands (Fig. 2D ). An unmanipulated wild-type C57BL/6J control mouse that received (Fig. 3C) . We then histopathologically characterized an aorta specimen that showed robust localization of the 
Discussion
Most acute vascular events result from sudden luminal thrombosis due to rupture of an atherosclerotic plaque. Preventing such complications of atherosclerosis is the most urgent need to improve the survival of patients with cardiovascular disease. Contrast-enhanced x-ray angiography, which is the gold standard imaging tool used in clinics, only identifies luminal anatomy and rarely captures arterial wall characteristics, although the association between plaque composition and lesion instability has become obvious 5 . Thus, accurate discrimination between stable and vulnerable plaques remains a clinical challenge 5, 7, 8, 13, 14 .
In the present study, we demonstrated the feasibility of SPECT/CT imaging with α v β 3 integrin-targeted atherosclerotic and normal aortas, respectively; P < 0.001). Autoradiography and histopathology corroborated the in vivo data by revealing specific vulnerable plaque characteristics such as a large necrotic core and a thin fibrous cap.
The biological insights and experimental knowledge in understanding key processes of atherosclerosis that contribute to a lesion's initiation, progression and complication have advanced markedly [9] [10] [11] [12] . This has spurred many efforts to develop molecular imaging strategies to identify destabilized atherosclerotic plaques that are likely provoke the onset of acute thrombotic events 13, 14, 16 . The cyclic peptide RGD is perhaps the best known ligand for targeting angiogenesis through its specific binding affinity for integrin α v β 3 and it has been widely used as a cancer diagnostic agent 21, 29, 30 . An increasing number of reports have recently indicated that angiogenesis is a very pertinent hallmark that can be used for staging atherosclerosis [17] [18] [19] . Shown in this study demonstrates successful application of RGD peptides to sensitively detect neoangiogenesis in high-risk lesions for clinical SPECT/CT imaging.
Focus of this study was particularly given to comparing monomeric and dimeric RGD-based tracers for gauging atherosclerosis. A direct comparison of Figure 4) , proving such sensitivity difference arise from intrinsic property of RGD derivatives not fluorophore conjugation. Enhanced specific targeting may be due to improved avidity to integrin α v β 3 of dimeric tracer over monomeric form as the interaction between integrins and their physiologic binding partners in the extracellular matrix involves multivalent binding sites with clustering of integrins.
Of note, the approach showcased in this study can be readily translated into the clinic, where its ultimate utility can be assessed. The noninvasive nuclear imaging technique SPECT has high sensitivity and quantification ability. The radionuclide other monomer RGD based strategies. As expected, based on our previous study 31 , the mean uptake of 99m
Tc-IDA-D-[c(RGDfK)] 2 in atherosclerotic plaques (2.98 ± 0.34%ID/g) was several folds lower (because of volume difference) than the uptake reported in α v β 3 integrin-expressing tumors (12.4 ± 3.89%ID/g) 31 .
Despite the small dimension of atherosclerotic lesions, our results suggest that visualization of high-risk plaques in human artery may be possible with α v β 3 integrin-specific SPECT/CT imaging. It must be highlighted that 99m
Tc-IDA-D-[c(RGDfK)] 2 depicts minimum background signal in chest SPECT/CT, which is especially beneficial for coronary artery imaging. By contrast, atherosclerosis imaging with 18 F-FDG PET has been suffered with great background myocardial uptake because of glucose consumption by the heart muscle itself 36 . In addition, 99m
Tc-IDA-D-[c(RGDfK)] 2 SPECT/CT may have an advantage over previous preclinical MRI studies for complete targeting of intraplaque microvessels because of the small probe size compared to MRI contrast agents, α v β 3 integrin-specific nanoparticles 25, 26 . To reach beyond the tools available in laboratory research, generalized, large, prospective clinical trials are needed to confirm the illustrated results of preclinical small animal imaging with 99m
Tc-IDA-D-[c(RGDfK)] 2 SPECT/CT. Typical atherosclerotic plaque regions that can be imaged in mouse models only include the larger vessels such as the abdominal aorta, the carotid arteries, the aortic arch, and the aortic root, as displayed in this report. It is challenging, but there is great interest in directly imaging thrombosis-prone plaques in small coronary arteries, which commonly cause acute myocardial infarction. Therefore, Mouse Model of Atherosclerosis. All animal experiments were carried out in accordance with the approved guidelines by the Seoul National University Bundang Hospital Animal Care and Use Committee. Apolipoprotein E knock out mice (male, n = 10) and C57BL/6J mice (male, n = 3) were purchased from the Jackson Laboratory (Bar Harbor, Maine, USA) at 8-10 weeks of age. The ApoE-/-mice were maintained on a high-cholesterol diet (0.2% total cholesterol, Harlan Laboratories, Indianapolis, IN, USA) for 40 weeks. At the time of imaging experiment, the mice had substantial atherosclerotic lesion growth resembling vulnerable plaques in humans. Wild-type mice with the C57BL/6J genetic background had been maintained on a regular diet and were used for the disease controls.
Animal SPECT/CT Imaging and Analysis. We anesthetized mice with 2% isoflurane gas anesthesia. The ApoE-/-mice were then administered intravenously reconstruction and quantification, respectively. The SPECT images were reconstructed to produce an image size of 176 × 176 × 136 voxels with a voxel size of 0.2 × 0.2 × 0.2 mm. The CT images were 48 μ m resolution acquisition with a voxel-pixel size of 0.20 : 0.192 mm. Details for image reconstruction and processing have been reported elsewhere 31 . Manually drawn two-dimensional regions of interest (ROIs) or three-dimensional volumes of interest (VOIs) were used to determine the accumulated radioactivity in units of %ID/g (with decay corrected to the time of injection) using 37-55.5 MBq radioactivity of 99m Tc as the reference source.
Statistical Analysis.
Comparisons between regions were performed using SPSS Statistics 19 (IBM, Armonk, NY, USA). All data were analyzed using SigmaStat software, version 3.5 (Systat Software, San Jose, CA, USA). Differences with a P value less than 0.001 were considered significant. Tc-IDA-D-[c(RADfK)] 2 , we dissected the aortic tissues of the atherosclerotic animals and laid these specimens flat on a phosphor imager (Fuji BAS-5000; Fujifilm Life Sciences, Stamford, USA) for 24 h. The generated autoradiographs were analyzed using a computer-based image analysis system (Multi Gauge software, Fujifilm Life Sciences). The specific uptake was expressed as photostimulated luminescence per millimeter squared (PSL/mm 2 ).
Autoradiography.
Histological Evaluation. To confirm the development of typical lipid-rich atherosclerotic plaques, the excised aortas were imaged intact. They then underwent Oil-Red-O staining. All photographic images were obtained by a digital camera.
To evaluate noninvasive imaging of atherosclerotic lesions, histopathology was performed on in vivo imaged aortas with an intense 99m Tc-IDA-D-[c(RGDfK)] 2 signal. After undergoing SPECT/CT and autoradiography imaging, the excised aortas were fixed with 10% formalin, embedded in paraffin, cut into 5-μ m sections and deparaffinized. The sections were subsequently stained with hematoxylin and eosin or Masson's trichrome stain to characterize the morphology and composition of the recorded peak signal of the aorta. Bright field color micrographs were obtained on a BX51 microscope equipped with DP71 camera (Olympus Optical Co., Ltd., Tokyo, Japan).
In Vitro Fluorescent Staining Assay in Plaque Tissue. Aorta tissues were dissected from apoE transgenic (ApoE-/-) mice (which were fed a high-cholesterol diet for 40 weeks) and wild-type C57BL/6J mice. The resected aortas were embedded in a tissue-freezing medium (Triangle Biomedical Sciences, Durham, NC, USA), frozen, and consecutively cryosectioned in 10-μ m segments using a Cryocut Microtome (CM3050S, Leica, Solms, Germany). The tissue sections were thaw-mounted onto silane-coated microscope slides (Muto Pure Chemicals co., Tokyo, Japan), dried in an aeration room, and stored at -80 °C until use. To confirm in vivo data and to compare plaque tissue binding ability, we performed fluorescence staining with QD605-D-[c(RGDfK)] 2 and QD605-c(RGDyK) on consecutive sections by the following steps: the 10-μ m sections were washed with phosphate-buffered saline (PBS) and incubated with either QD605-D-[c(RGDfK)] 2 or QD605-c(RGDyK) (10 pmol of peptide, 4 μ g of QD605) for 30 min. The slides were then washed with PBS several times, counterstained with Hoechst33342 and mounted with Prolong Gold Antifade Reagent (Life Technologies, Carlsbad, CA, USA). The fluorescence images were captured with a confocal microscope (TCS NT4D, Leica, Solms, Germany) to identify the binding difference between the two agents.
